Advertisement

Topics

Sanofi Files Suit Against Merck, Defending Insulin Patent Rights

10:30 EDT 9 Aug 2017 | PharmPro

Sanofi files suit in the U.S. to defend its patent rights on Lantus®.
Contributed Author: 
Nasdaq
Topics: 

Original Article: Sanofi Files Suit Against Merck, Defending Insulin Patent Rights

NEXT ARTICLE

More From BioPortfolio on "Sanofi Files Suit Against Merck, Defending Insulin Patent Rights"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...